News | January 31, 2011

FDA Approves Treatment System for Uterine Fibroids, Liver Cancer

January 31, 2011 – The U.S. Food and Drug Administration (FDA) has approved a system for accessing and delivering diagnostic, embolic and therapeutic materials into the peripheral vasculature. The Renegade HI-FLO Fathom Pre-Loaded System, by Boston Scientific, will be used by interventional radiologists for minimally invasive procedures to treat uterine fibroids and liver cancer.

The system combines the turn-for-turn torque response, flexibility and high visibility of the Fathom-16 Steerable Guidewire with the clinically proven performance of the Renegade HI-FLO Microcatheter, pre-loaded in a single convenient platform. It will be available in eight configurations to suit a broad range of peripheral embolization procedures.

"The excellent deliverability, torque transmission and flow capacity of the Renegade HI-FLO Fathom Pre-Loaded System provides physicians with the performance they need to efficiently access tortuous vessels across many types of interventional oncology procedures," said Jeff Geschwind, M.D., professor of radiology, surgery and oncology, and director of vascular and interventional radiology at the Johns Hopkins University School of Medicine. "Having the Fathom-16 Guidewire pre-loaded in the Renegade HI-FLO Microcatheter will reduce my procedural preparation time and the number of devices that my staff must manage."

Uterine fibroids are non-cancerous growths that develop in the muscular wall of the uterus or cervix, and are estimated to occur in up to 40 percent of women of child-bearing age. Although most uterine fibroids are asymptomatic, some can cause heavy and painful menstrual bleeding, pelvic pressure and frequent urination. Treatment options include medication, hysterectomy, myomectomy (surgical removal of fibroids from the uterus) and uterine artery embolization (UAE). In UAE, a physician uses minimally invasive techniques under local anesthesia to access and occlude both uterine arteries, reducing or eliminating blood flow to the fibroid. Uterine fibroids are the most common benign tumors in women and are the most frequent indication for hysterectomy among pre-menopausal women.

Liver cancer is one of the most commonly diagnosed forms of cancer worldwide, with more than 800,000 patients diagnosed annually. The average life expectancy of many patients with liver cancer is less than one year. Treatment options include surgical resection, chemotherapy, radiation, tumor ablation and several minimally invasive options, including transarterial chemoembolization (TACE) and radioembolization. In the minimally invasive options, a physician will establish endovascular access to the hepatic artery under local anesthesia to deliver one of several acute therapies.

For more information: www.bostonscientific.com

Related Content

Image courtesy of Philips

Image courtesy of Philips

Feature | Interventional Radiology | July 05, 2018 | By Jeff Zagoudis
On May 14, 2018, First Lady Melania Trump underwent an embolization procedure for what was called a benign kidney...
Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
Technology | Interventional Radiology | June 29, 2018
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation...
Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018
Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumor and vascular...
Melania Trump in hospital to undergo an interventional radiology (IR) catheter embolization procedure in her kidneys. Angiogram of a kidney.

First Lady Melania Trump in hospital to undergo an interventional radiology (IR) catheter embolization procedure in her kidneys. The left image is an example of a kidney angiogram to highlight the renal blood vessels during an interventional procedure.

News | Interventional Radiology | May 15, 2018 | Dave Fornell
May 15, 2018 — U.S.
Capitol Hill Briefing Explores Role of Interventional Radiology in Healthcare
News | Interventional Radiology | May 09, 2018
The Society of Interventional Radiology (SIR), in conjunction with Rep. Mia Love (R-Utah) participated in a panel...
Body Vision Medical Receives FDA Clearance for LungVision Tool
Technology | Lung Cancer | May 09, 2018
Body Vision Medical received clearance from the U.S. Food and Drug Administration (FDA) to market their LungVision Tool...
360 Photos | Angiography | May 03, 2018
A 360 degree view of the newest cath lab at...
El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy
News | Oncology Diagnostics | April 25, 2018
The interventional pulmonology team at the Taft Center for Clinical Research at El Camino Hospital in Mountain View,...
GE's OEC Elite CFD

GE's OEC Elite CFD

Feature | Mobile C-Arms | April 18, 2018 | Jeff Zagoudis
The market for mobile C-arm techn...
Medical Societies Issue Revised, Patient-Centered Measures for Stroke Interventions
News | Stroke | April 02, 2018
Revised guidelines for the nonsurgical, image-guided interventional treatment of acute ischemic stroke will ensure...
Overlay Init